|Articles|November 18, 2003
Corneal collagen crosslinking safely halts keratoconus progression
Crosslinking of corneal collagen by topical treatment with riboflavinand ultraviolet light exposure shows promise as a safe and effective nonsurgicaltreatment for keratoconus, according to data presented by Theo Seiler, MD,PhD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
2
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
3
iOpeners with Nicole Bajic, MD: Nikolina Budimlija, MD, on building a multidisciplinary dry eye clinic in Ireland
4
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
5






















